Cholera toxin induces synthesis of phospholipase A2-activating protein

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 2137-2143

  Peterson, Johnny W ^a   Saini, Shamsher S ^a   Dickey, William D ^a   Klimpel, Gary R ^a   Bomalaski, John S ^b   Clark, Mike A ^c   Xu, Xin Jing ^a   Chopra, Ashok K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Enzon Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CHOLERA TOXIN; CYCLIC AMP; MESSENGER RNA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; REGULATOR PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CHOLERA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINE MUSCLE; MOUSE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

EID: 0029967333     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.2137-2143.1996     Document Type: Article

References (38)

1. Arnold, W. J., D. W. Niesel, C. A. Annable, C. B. Hess, M. Asuncion, Y. J. Cho, J. W. Peterson, and G. R. Kumpel. 1993. Tumor necrosis factor alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb. Pathog. 14:217-227.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology. John Wiley & Sons, New York.
3. 2-mediated secretory response to 5-hydroxytryptamine in the small intestine of the rat in vivo. Gastroenterology 90:1972-1977.
4. 2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroentcrology 96:368-376.
5. 2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. J. Immunol. 142:3957-3962.
6. 2 and arthritis. Arthritis Rheum. 36:190-198.
7. 2-activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J. Lab. Clin. Med. 116:814-825.
8. 2-activating protein induces the synthesis of IL-1 and TNF in human monocytcs. J. Immunol. 154:4027-4031.
9. 2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. J. Immuno. 148:155-160.
10. 2 synthesis in a murine macrophage cell line. J. Pharm. Exp. Ther. 244:765-773.
11. Chopra, A. K., J. W. Peterson, P. Chary, and R. Prasad. 1994. Molecular characterization of an entetoxin from Salmonella typhimurium. Microb. Pathog. 16:85-98.
12. 2-activating protein in endothelial cells. Biochem. J. 250: 125-132.
13. 2 stimulatory peptide melittin. J. Biol. Chem. 262:4402-4406.
14. 2-activating protein. Proc. Natl. Acad. Sci. USA 88:5418-5422.
15. Eklund, S., J. Cassuto, M. Jodal, and O. Lundgren. 1984. The involvement of the enteric nervous system in the intestinal secretion evoked by cyclic adenosine 3′,5′-monophosphate. Acta Physiol. Scand. 120:311-316.
16. Finkelstein, R. A., J. J. Jehl, and A. Goth. 1969. Pathogenesis of experimental cholera: choleragen-induced rat foot edema: a method of screening anticholera drugs. Proc. Soc. Exp. Biol. Med. 132:835-840.
17. Giannella, R. A., S. B. Formal, G. J. Dammin, and H. Collins. 1973. Pathogenesis of salmonellosis: studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J. Clin. Invest. 52:441-453.
18. Grayer, D. T., H. R. Serebro, F. L. Iber, and T. R. Hendrix. 1970. Effect of cycloheximide on unidirectional sodium fluxes in the jejunum after cholera exotoxin exposure. Gastroentcrology 58:815-819.
19. Haberman, E. 1971. Bee and wasp venoms. Science 117:314-322.
20. Kimberg, D. V., M. Field, E. Gershon, R. T. Schooley, and A. Henderson. 1973. Effects of cycloheximide on the response of intestinal mucosa to cholera enterotoxin. J. Clin. Invest. 52:1376-1383.
21. Lexomboon, U., A. Goth, and R. A. Finkelstein. 1971. Applications of the mouse foot edema lest in evaluation of anti-cholera drugs. Res. Commun. Chem. Pathol. Pharmacol. 2:245-259.
22. Moritz, M., F. L. Iber, and E. W. Moore. 1972. Rabbit cholera: effects of cycloheximide on net water and ion fluxes and transmural electric potentials. Gastroenterology 637:76-82.
23. Moss, J., and M. Vaughn. 1988. Cholera toxin and E. coli enterotoxins and their mechanisms of action, p. 39-87. In M. C Hardegree and A. T. Tu (ed.), Handbook of natural toxins, vol. 4. Bacterial toxins. Marcel Dekker, Inc., New York.
24. β-subunits: a new concept of effector protein activation in signal transduction. Trends Biochem. Sci 18: 292-293.
25. Peterson, J. W., W. D. Berg, and D. H. Coppenhaver. 1987. Synthesis of protein in intestinal cells exposed to cholera toxin. Proc. Soc. Exp. Biol. Med. 186:174-182.
26. Peterson, J. W., J. Cantu, S. Duncan, and A. K. Chopra. 1993. Molecular mediators formed in the small intestine in response to cholera toxin. J. Diarrhoeal Dis. Res. 11:227-234.
27. Peterson, J. W., C. A. Jackson, and J. C. Reitmeyer. 1990. Synthesis of prostaglandins in cholera toxin-treated Chinese hamster ovary cells. Microb. Pathog. 9:345-353.
28. Peterson, J. W., Y. Lu, S. Duncan, J. Cantu, and A. K. Chopra. 1994. Interactions of intestinal mediators in the mode of action of cholera toxin. J. Med. Microhiol. 41:3-9.
29. Peterson, J. W., N. C. Molina, C. W. Houston, and R. C. Fader. 1983. Elevated cAMP in intestinal epithelial cells during experimental cholera and salmonellosis. Toxicon 21:761-775.
30. Peterson, J. W., and L. Ochoa. 1989. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245:857-859.
31. Peterson, J. W., J. C. Reitmeyer, C. A. Jackson, and G. A. S. Ansari. 1991. Protein synthesis is required for cholera toxin-induced stimulation of arachidonic acid metabolism. Biochim. Biophys. Acta 1092:79-84.
32. Powell, D.W. 1991. Immunophysiology of intestinal electrolyte transport, p. 591-641. In R. A. Frizzell and M. Field (ed.). Handhook of physiology. The gastrointestinal system, vol. IV. Absorptive and secretory processes of the intestine. Waverly Press, Baltimore.
33. Prasad, R., A. K. Chopra, P. Chary, and J. W. Peterson. 1992. Expression and characterization of the cloned Salmonella typhimurium enterotoxin. Microb. Pathog. 13:109-121.
34. Prasad, R., A. K. Chopra, J. W. Peterson, R. Pericas, and C. W. Houston. 1990. Biological and immunological characterization of a cloned cholera toxin-like enterotoxin from Salmonella typhimurium. Microb. Pathog. 9:315-329.
35. Reitmeyer, J. C., and J. W. Peterson. 1990. Stimulatory effects of cholera toxin on arachidonic acid metabolism in Chinese hamster ovary cells. Proc. Soc. Exp. Biol. Med. 193:181-184.
36. Serebro, H. A., F. L. Iber, J. H. Yardley, and T. R. Hendrix. 1969. Inhibition of cholera toxin action in the rabbit by cycloheximide. Gastroenterology 56:506-511.
37. 2 concentrations in patients with acute cholera. Gut 26:188-193.
38. 2 in patients with acute cholera. Gut 33:643-645.